Unknown Manufacturer
Farletuzumab (MORAb-003) is a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.
Farletuzumab (MORAb-003) is a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.
Investigated for use/treatment in ovarian cancer.
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
